NZSE - Delayed Quote NZD
Comvita Limited (CVT.NZ)
0.7900 -0.0400 (-4.82%)
At close: 4:59:58 pm NZST
Chart Range Bar
Loading chart for CVT.NZ
- Previous close
0.8300 - Open
0.8300 - Bid 0.7900 x 351000
- Ask 0.8000 x 350000
- Day's range
0.7900 - 0.8350 - 52-week range
0.4300 - 0.8350 - Volume
50,306 - Avg. Volume
34,782 - Market cap (intra-day)
102.573M - Beta (5Y monthly) --
- PE ratio (TTM)
7.90 - EPS (TTM)
0.1000 - Earnings date (est.) --
- Forward dividend & yield --
- Ex-dividend date 3 Apr 2024
- 1y target est
--
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in the apiary ownership and forest management activities. The company sells its products online through its website. Comvita Limited was founded in 1974 and is based in Te Puke, New Zealand.
www.comvita.co.nz--
Full-time employees
30 June
Fiscal year ends
Consumer Defensive
Sector
Packaged Foods
Industry
Recent news
View more
Performance overview
Trailing total returns as of 1/09/2026, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) .
YTD return
CVT.NZ
0.00%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
1.76%
1-year return
CVT.NZ
6.76%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
5.48%
3-year return
CVT.NZ
74.97%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
19.59%
5-year return
CVT.NZ
77.20%
S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50)
4.10%
Statistics
View moreValuation measures
As of 28/08/2026
Market cap
118.44M
Enterprise value
186.13M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.31
Price/book (mrq)
1.02
Enterprise value/revenue
0.97
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
3.64%
Return on assets (ttm)
5.18%
Return on equity (ttm)
10.21%
Revenue (ttm)
212.96M
Net income avi to common (ttm)
7.74M
Diluted EPS (ttm)
0.1000
Balance sheet and cash flow
Total cash (mrq)
13M
Total debt/equity (mrq)
31.55%
Levered free cash flow (ttm)
32.64M
Compare
Select to analyse similar companies using key performance metrics; select up to four stocks.